Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1482 Articles

Lee Jackson | Aug 31, 2016 at 8:20 AM EDT

3 Biotech Stocks Could Be the Next Big Takeover Targets

In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative…

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Aug 22, 2016 at 7:55 AM EDT

Pfizer Pays a Big Premium for Medivation

In one of the longest running bidding wars in recent times, Pfizer has finally reeled in cancer-drug maker Medivation.

Jon C. Ogg | Aug 18, 2016 at 12:50 PM EDT

How Much Medivation Can Really Fetch in a Buyout

Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have…

Paul Ausick | Aug 17, 2016 at 4:01 PM EDT

3M, Chevron Pull Dow Higher Wednesday

August 17, 2016: Markets opened slightly lower Wednesday following a slide in European markets. Utility stocks were the leading sector…

Jon C. Ogg | Aug 15, 2016 at 1:05 PM EDT

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for…

Jon C. Ogg | Aug 13, 2016 at 9:15 AM EDT

10 Merrill Lynch Equity Income Portfolio Picks for Safe High-Dividend Yields

In the latest Merrill Lynch RIC Report, which is effectively a culmination of the firm's top research ideas, views and…

Jon C. Ogg | Aug 11, 2016 at 4:33 PM EDT

5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday

The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that…

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 10, 2016 at 8:05 AM EDT

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

The short interest data for the July 29 settlement date are out and it almost feels like short sellers are…

Paul Ausick | Aug 8, 2016 at 4:01 PM EDT

Healthcare Stocks Sink DJIA on Monday

August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red…

Paul Ausick | Aug 8, 2016 at 7:55 AM EDT

Why Allergan Earnings Aren’t Telling the Whole Story

Allergan reported mixed second-quarter 2016 results and announced share buybacks before markets opened Monday morning.

Paul Ausick | Aug 2, 2016 at 4:01 PM EDT

Apple, Pfizer Sink DJIA on Tuesday

August 2, 2016: Markets opened nearly flat again Tuesday on stronger oil prices early in the day before reality set…

Chris Lange | Aug 2, 2016 at 9:05 AM EDT

Pfizer Earnings Fail to Impress Investors

When Pfizer reported its second-quarter financial results before the markets opened on Tuesday, investors initially did not appear impressed.

Chris Lange | Aug 1, 2016 at 11:25 AM EDT

What to Expect From Pfizer Earnings

The upcoming earnings report will showcase what Pfizer has to offer for the second half of 2016, and potentially give…

1 … 46 47 48 49 50 … 99

Pfizer : PFE

All Pfizer Articles

3 Biotech Stocks Could Be the Next Big Takeover Targets

Major Pharma Short Interest Faces Significant Drop

Pfizer Pays a Big Premium for Medivation

How Much Medivation Can Really Fetch in a Buyout

3M, Chevron Pull Dow Higher Wednesday

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

10 Merrill Lynch Equity Income Portfolio Picks for Safe High-Dividend Yields

5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday

Major Pharma Short Interest Slides

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

Healthcare Stocks Sink DJIA on Monday

Why Allergan Earnings Aren’t Telling the Whole Story

Apple, Pfizer Sink DJIA on Tuesday

Pfizer Earnings Fail to Impress Investors

What to Expect From Pfizer Earnings

Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

Live: Can Lululemon’s Q1 Earnings Tonight Spark a Recovery?

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Pfizer : PFE

All Pfizer Articles

3 Biotech Stocks Could Be the Next Big Takeover Targets

Major Pharma Short Interest Faces Significant Drop

Pfizer Pays a Big Premium for Medivation

How Much Medivation Can Really Fetch in a Buyout

3M, Chevron Pull Dow Higher Wednesday

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

10 Merrill Lynch Equity Income Portfolio Picks for Safe High-Dividend Yields

5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday

Major Pharma Short Interest Slides

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

Healthcare Stocks Sink DJIA on Monday

Why Allergan Earnings Aren’t Telling the Whole Story

Apple, Pfizer Sink DJIA on Tuesday

Pfizer Earnings Fail to Impress Investors

What to Expect From Pfizer Earnings

Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

Live: Can Lululemon’s Q1 Earnings Tonight Spark a Recovery?

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Featured Reads

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life